• Greater Twin Cities: 715.294.4371

  • Search

Purchase Prednisone tablets online

How and where to order Deltasone, Prednisone 5, 10, 20, 40 mg pills online:

Prices: from $0.29 per pill
Discount: 10% coupon: DFH10
Forms: Prednisone, Deltasone 5 mg, 10 mg, 20 mg, 40 mg tablets or capsules
Quantity: 20-360 pills
Type: Prednisone brand, Deltasone generic
Payment: Visa, Mastercard, AmEx, Bitcoin
Delivery: Standard airmail and trackable courier service
Shipping: Worldwide, including USA, UK, Europe, Canada, Australia

Prednisone (trade names include Deltasone, Apo-Prednisone, Cortancyl, Dacortin, Prednison Hexal, Decortin, Prednisona Cinfa Laboratorios, Deltacortene, Encorton, Prednisone Arrow Generiques, Lodotra, Meticorten, Novo-Prednisone, Orasone, Prednisone Mylan, Panafcort, Prednisone Roxane Laboratories, Predni Tablinen, Prednisone Sandoz, Pulmison, Rectodelt, Teva-Prednisone) is a glucocorticosteroid (glucocorticoid, GCS) medication for local and systemic use. This medicine is indicated for the treatment of various diseases and medical conditions such as severe allergic reactions (including allergic rhinitis, allergic conjunctivitis, skin rash), certain types of arthritis (like gouty arthritis, rheumatoid arthritis, giant-cell arteritis, rheumatologic diseases, juvenile rheumatoid arthritis, osteoarthritis, psoriatic arthritis); rheumatic disorders, inflammatory conditions, chronic inflammatory demyelinating polyneuropathy (CIDP), bursitis, tennis elbow (lateral epicondylitis), erythroblastopenia, thrombocytopenia, idiopathic thrombocytopenic purpura, syphilis, herpes zoster, herpes zoster iridocyclitis, shingles, immunosuppression (for example to prevent rejection after organ transplant), pericarditis, decompensated heart failure, uveitis, posterior uveitis, keratitis, corneal ulcer, synovitis, lupus, systemic lupus erythematosus, scleroderma, eczema, severe psoriasis, dermatitis herpetiformis, atopic dermatitis, dermatomyositis, seborrheic dermatitis, toxic epidermal necrolysis, poison oak exposure, polymyositis, mycosis fungoides, mixed connective tissue disease, ankylosing spondylitis, severe asthma, chronic obstructive pulmonary disease (COPD), coronavirus (COVID-19), aspiration pneumonia, lipid pneumonitis, migraine headaches, cluster headaches, fibromyalgia, nephrotic syndrome, neurosarcoidosis, sarcoidosis, endocrine (hormonal) disorders, ulcerative colitis, severe aphthous ulcer, inflammatory bowel disease, berylliosis, chorioretinitis, iritis, iridocyclitis, Crohn's disease, Cogan's syndrome, Loeffler's syndrome, Meniere's disease, Herxheimer reaction, Duchenne muscular dystrophy, Ramsay hunt syndrome, Graft-versus-host disease, granulomatosis with polyangiitis, lichen planus, lichen sclerosus, multiple sclerosis, systemic sclerosis, myasthenia gravis, pemphigoid, bullous pemphigoid, pemphigus, autoimmune hemolytic anemia, autoimmune hepatitis, other autoimmune diseases, thyroiditis, laryngitis, pharyngitis, sinusitis, urticaria (hives), tuberculous meningitis, severe tuberculosis, extrapulmonary tuberculosis, hypercalcemia (high blood calcium) due to cancer, adrenal insufficiency, adrenocortical insufficiency, adrenogenital syndrome; allergic disorders, and other conditions that affect skin, lungs, eyes, thyroid, kidneys blood, stomach and intestines. Sometimes it is used as antitumor drug to treat symptoms of certain types of cancer such as acute lymphocytic leukemia (acute lymphoblastic leukemia), diffuse large B-cell lymphoma, non-Hodgkin lymphomas, Hodgkin's lymphoma, multiple myeloma, hypercalcemia of malignancy, other hormone-sensitive tumors, in combination with other anticancer drugs. Prednisone is wiledly used in veterinary for dogs, cats, other pets and animals. This medication works by decreasing or preventing tissues from responding to inflammation. It also modifies the body's response to certain immune stimulation.

Prednisone tablets bottle

Related medications:

  • Beclometasone (Beclomethasone)
  • Betamethasone (Diprolene)
  • Budesonide (Pulmicort)
  • Celecoxib (Celebrex)
  • Clobetasol (Temovate)
  • Cortisone (Cortone)
  • Dexamethasone (Dexone)
  • Diclofenac (Voltaren)
  • Estradiol (Estrace)
  • Hydrocortisone (Solu-Cortef)
  • Indomethacin (Indocin)
  • Leflunomide (Arava)
  • Lidocaine (Xylocaine)
  • Loteprednol (Lotemax)
  • Mefenamic Acid (Ponstel)
  • Meloxicam (Mobic)
  • Methylprednisolone (Medrol)
  • Nabumetone (Relafen)
  • Paramethasone (Dillar)
  • Prednisolone (Millipred DP)
  • Triamcinolone (Aristocort)

    Pharmacological and medical categories:

  • Adrenals
  • Anti inflammatory agents
  • Anti cancer drugs
  • Antihistamines and antiallergics
  • Corticosteroid hormones
  • Eye corticosteroids
  • Glucocorticoids (GCS)
  • Immunosuppressant drugs
  • Topical corticosteroids for the treatment of dermatological diseases
  • Veterinary, pet meds

    ATC codes:

  • A - Alimentary tract and metabolism
  • A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents
  • A07E - Intestinal antiinflammatory agents
  • A07EA - Corticosteroids acting locally
  • A07EA03 - Prednisone

  • H - Systemic hormonal preparations, excl. sex hormones and insulins
  • H02 - Corticosteroids for systemic use
  • H02A - Corticosteroids for systemic use, plain
  • H02AB - Glucocorticoids
  • H02AB07 - Prednisone

    ICD-10 codes:

  • Respiratory tuberculosis - A15
  • Tuberculosis of nervous system - A17
  • Tuberculous meningitis - A17.0
  • Infections with a predominantly sexual mode of transmission - A50-A64
  • Other and unspecified syphilis - A53
  • Zoster [herpes zoster] - B02
  • Postherpetic geniculate ganglionitis - B02.21
  • Zoster iridocyclitis - B02.32
  • Zoster without complications - B02.9
  • Viral infection of unspecified site - B34
  • Coronavirus infection, unspecified - B34.2
  • Candidiasis - B37
  • Neoplasms - C00-D48
  • Hodgkin lymphoma - C81
  • Non-follicular lymphoma - C83
  • Diffuse large B-cell lymphoma - C83.3
  • Mature T/NK-cell lymphomas - C84
  • Mycosis fungoides - C84.0
  • Other specified and unspecified types of non-Hodgkin lymphoma - C85
  • Multiple myeloma and malignant plasma cell neoplasms - C90
  • Lymphoid leukemia - C91
  • Acquired hemolytic anemia - D59
  • Acquired pure red cell aplasia [erythroblastopenia] - D60
  • Purpura and other hemorrhagic conditions - D69
  • Immune thrombocytopenic purpura - D69.3
  • Thrombocytopenia, unspecified - D69.6
  • Other disorders of white blood cells - D72
  • Eosinophilia - D72.1
  • Certain disorders involving the immune mechanism - D80-D89
  • Sarcoidosis - D86
  • Other disorders involving the immune mechanism, not elsewhere classified - D89
  • Graft-versus-host disease - D89.81
  • Endocrine, nutritional and metabolic diseases - E00-E89
  • Thyroiditis - E06
  • Adrenogenital disorders - E25
  • Other disorders of adrenal gland - E27
  • Primary adrenocortical insufficiency - E27.1
  • Disorders of mineral metabolism - E83
  • Hypercalcemia - E83.52
  • Multiple sclerosis - G35
  • Migraine - G43
  • Other headache syndromes - G44
  • Cluster headaches and other trigeminal autonomic cephalgias (TAC) - G44.0
  • Inflammatory polyneuropathy - G61
  • Chronic inflammatory demyelinating polyneuritis - G61.81
  • Myasthenia gravis and other myoneural disorders - G70
  • Primary disorders of muscles - G71-
  • Muscular dystrophy - G71.0
  • Conjunctivitis - H10
  • Other chronic allergic conjunctivitis - H10.45
  • Keratitis - H16
  • Corneal ulcer - H16.0
  • Diffuse interstitial keratitis, unspecified eye - H16.329
  • Iridocyclitis - H20
  • Unspecified acute and subacute iridocyclitis - H20.00
  • Chorioretinal inflammation - H30
  • Disorders of vestibular function - H81
  • Meniere's disease, unspecified ear - H81.09
  • Acute pericarditis - I30
  • Heart failure - I50
  • Haemorrhoids - I84
  • Acute sinusitis - J01
  • Acute pharyngitis - J02
  • Acute laryngitis and tracheitis - J04
  • Vasomotor and allergic rhinitis - J30
  • Other chronic obstructive pulmonary disease - J44
  • Asthma - J45
  • Pneumoconiosis due to other inorganic dusts - J63
  • Berylliosis - J63.2
  • Pneumonitis due to solids and liquids - J69
  • Pneumonitis due to inhalation of food and vomit - J69.0
  • Pneumonitis due to inhalation of oils and essences - J69.1
  • Stomatitis and related lesions - K12
  • Recurrent oral aphthae - K12.0
  • Crohn's disease [regional enteritis] - K50
  • Ulcerative colitis - K51
  • Fissure and fistula of anal and rectal regions - K60
  • Other inflammatory liver diseases - K75
  • Autoimmune hepatitis - K75.4
  • Pemphigus - L10
  • Pemphigoid - L12
  • Bullous pemphigoid - L12.0
  • Other bullous disorders - L13
  • Dermatitis herpetiformis - L13.0
  • Dermatitis and eczema - L20-L30
  • Atopic dermatitis - L20
  • Seborrheic dermatitis - L21
  • Allergic contact dermatitis - L23
  • Allergic contact dermatitis due to plants, except food - L23.7
  • Irritant contact dermatitis - L24
  • Pruritus - L29
  • Other dermatitis - L30
  • Psoriasis - L40
  • Psoriatic arthritis mutilans - L40.52
  • Lichen planus - L43
  • Urticaria - L50
  • Erythema multiforme - L51
  • Toxic epidermal necrolysis [Lyell] - L51.2
  • Atrophic disorders of skin - L90
  • Lichen sclerosus et atrophicus - L90.0
  • Rheumatoid arthritis with rheumatoid factor - M05
  • Other rheumatoid arthritis - M06
  • Gout - M10
  • Osteoarthritis - M15-M19
  • Systemic connective tissue disorders - M30-M36
  • Other necrotizing vasculopathies - M31
  • Other giant cell arteritis - M31.6
  • Systemic lupus erythematosus (SLE) - M32
  • Dermatopolymyositis - M33
  • Polymyositis - M33.2
  • Systemic sclerosis [scleroderma] - M34
  • Other systemic involvement of connective tissue - M35
  • Systemic involvement of connective tissue, unspecified - M35.9
  • Ankylosing spondylitis - M45
  • Synovitis and tenosynovitis - M65
  • Soft tissue disorders related to use, overuse and pressure - M70
  • Other bursopathies - M71
  • Bursopathy, unspecified - M71.9
  • Other enthesopathies M77
  • Lateral epicondylitis - M77.1
  • Other and unspecified soft tissue disorders, not elsewhere classified - M79
  • Rheumatism, unspecified - M79.0
  • Fibromyalgia - M79.7
  • Nephrotic syndrome - N04
  • Other inflammation of vagina and vulva - N76
  • Rash and other nonspecific skin eruption - R21
  • Other general symptoms and signs - R68
  • Herxheimer's reaction - R68.89
  • Adverse effects, not elsewhere classified - T78
  • Need for other prophylactic measures - Z29
  • Personal history of medical treatment - Z92
  • Personal history of immunosupression therapy - Z92.25

    Indications and usage:

    Prednisone in a pharmaceutical form of corticosteroid tablets is indicated:

  • as an anti-inflammatory or immunosuppressive agent for certain allergic, dermatologic, gastrointestinal, hematologic, ophthalmologic, nervoussystem, renal, respiratory, rheumatologic, specific infectious diseases or conditions and organ transplantation
  • for the treatment of certain endocrine conditions
  • for palliation of certain neoplastic conditions

    Dosage and administration:

    Individualize dosing based on disease severity and patient response. The timing of administration should take into account the delayed-release pharmacokinetics and the disease or condition being treated:

  • Initial dose: prednisone 5 mg administered once per day. Patients currently on immediate-release prednisone, prednisolone, or methylprednisolone should be switched to prednisone at an equivalent dose based on relative potency.
  • Maintenance dose: use lowest dosage that will maintain an adequate clinical response.
  • Discontinuation: withdraw gradually if discontinuing long-term or high-dose therapy.
  • Prednisone should be taken daily with food.
  • This medication should be swallowed whole and not broken, divided, or chewed.


    The effects of accidental ingestion of large quantities of prednisone over a very short period of time have not been reported, but prolonged use of the drug can produce mental symptoms, moon face, abnormal fat deposits, fluid retention, excessive appetite, weight gain, hypertrichosis, acne, striae, ecchymosis, increased sweating, pigmentation, dry scaly skin, thinning scalp hair, increased blood pressure, tachycardia, thrombophlebitis, decreased resistance to infection, negative nitrogen balance with delayed bone and wound healing, headache, weakness, menstrual disorders, accentuated menopausal symptoms, neuropathy, fractures, osteoporosis, peptic ulcer, decreased glucose tolerance, hypokalemia, and adrenal insufficiency.Hepatomegaly and abdominal distention have been observed in children.

    Treatment of acute overdosage is by immediate gastric lavage or emesis followed by supportive and symptomatic therapy. For chronic overdosage in the face of severe disease requiring continuous steroid therapy the dosage of prednisone may be reduced only temporarily, or alternate day treatment may be introduced.

    Dosage forms and strengths:

    Prednisone 1 mg, 2 mg, 5 mg, 10 mg, 20 mg, 40 mg tablets for oral use.


    Known hypersensitivity to prednisone or any excipients in the formulation.

    Warnings and precautions:

  • Hypothalamic-pituitary-adrenal (HPA) axis suppression, Cushing's syndrome, and hyperglycemia: monitor patients for these conditions with chronic use. Taper doses gradually for withdrawal after chronic use.
  • Infections: increased susceptibility to new infection and increased risk of exacerbation, dissemination, or reactivation of latent infection. Signs and symptoms of infection may be masked.
  • Elevated blood pressure, salt and water retention, and hypokalemia: monitor blood pressure and sodium, potassium serum levels.
  • GI perforation: increased risk in patients with certain GI disorders. Signs and symptoms may be masked.
  • Behavioral and mood disturbances: may include euphoria, insomnia, mood swings, personality changes, severe depression, and psychosis. Existing conditions may be aggravated.
  • Decreases in bone density: monitor bone density in patients receiving long term corticosteroid therapy.
  • Ophthalmic effects: may include cataracts, infections, and glaucoma. Monitor intraocular pressure if corticosteroid therapy is continued for more than 6 weeks.
  • Live or live attenuated vaccines: do not administer to patients receiving immunosuppressive doses of corticosteroids.
  • Negative effects on growth and development: monitor pediatric patients on long-term corticosteroid therapy.
  • Embryo-Fetal toxicity: can cause fetal harm with first trimester use. Advise patientsofpotential harm to the fetus.

    Adverse reactions, side effects:

    Common adverse reactions for prednisone and other corticosteroids include fluid retention, alteration in glucose tolerance, elevation in bl ood pressure, behavioraland mood changes, increased appetite and weight gain.

    To report suspected side effects of prednisone contact your local FDA.

    Drug interactions:

  • Anticoagulant agents: prednisone may enhance or diminish anticoagulant effects.
  • Antidiabetic agents: may increase blood glucose concentrations. Dose adjustments of antidiabetic agents may be required.
  • CYP 3A4 inducers and inhibitors: may, respectively, increase or decrease clearance of corticosteroids, necessitating dose adjustment.
  • Cyclosporine: increase in activity of both, cyclosporine and corticosteroid when administered concurrently. Convulsions have been reported with concurrent use.
  • NSAIDs including aspirin and salicylates: Increased risk of gastrointestinal side effects.

    Patient counseling information:

    Patients should be informed of the following information before initiating therapy with prednisone and periodically during the course of ongoing therapy.

  • Patients should be warned not to discontinue the use of prednisone abruptly or without medical supervision, to advise any medical attendants that they are taking it, and to seek medical advice at once should they develop fever or other signs of infection. Patients should be told to take prednisone exactly as prescribed, followthe instructions on the prescription label, and not stop taking this medication without first checking with their healthcare providers, as there may be a need for gradual dose reduction.
  • Patients should discuss with their physician if they have had recent or ongoing infections or if they have recently received a vaccine.
  • Persons who are on immunosuppressant doses of corticosteroidsshould be warned to avoid exposure to chickenpox or measles. Patients should also be advised that if they are exposed, medical advice should be sought without delay.
  • There are a number of medicines that can interact with prednisone. Patients should inform their healthcare provider of all the medicines they are taking, including over-the-counter and prescription medicines (such as phenytoin, diuretics, digitalis or digoxin, rifampin, amphotericin B, cyclosporine, insulin or diabetes medicines, ketoconazole, estrogens including birth control pills and hormone replacement therapy, blood thinners such as warfarin, aspirin or other NSAIDS, barbiturates), dietary supplements, and herbal products. If patients are taking any of these drugs, alternate therapy, dosage adjustment, and/or special test may be needed during the treatment.
  • For missed doses, patients should be told to take the missed dose as soon as they remember. If it is almost time for the next dose, the missed dose should be skipped and the medicine taken at thenext regularly schedule time. Patients should not take an extra dose to make up for the missed dose.
  • Patients should be told to take prednisone with food. Patients should be advised not to break, divide, or chew this medicine.
  • Patients should be advised of common adverse reactions that could occur with prednisone use to include fluid retention, alteration in glucose tolerance, elevation in blood pressure, behavioral and mood changes, increased appetite and weight gain.
  • Advise pregnant women and females of reproductive potential of the potential risk to a fetus. Advise females to inform their healthcare provider of a known or suspected pregnancy.

    Pregnancy categories:

  • A - Australia
  • C - United States (Risk cannot be ruled out)
  • D - United States (Positive evidence of risk) for delayed-release tablets

    Salts and other forms:

  • Prednisone Base
  • Prednisone Acetate
  • Prednisone Hemisuccinate

    Synonyms, international and chemical names:

  • 1,4-Pregnadiene-17alpha,21-diol-3,11,20-trione
  • 17,21-Dihydroxypregna-1,4-diene-3,11,20-trione
  • Dehydrocortisone
  • Delta-1-Cortisone
  • Delta-1-Dehydrocortisone
  • Prednison
  • Prednisona
  • Prednisoni
  • Prednisonum
  • Prednisoon
  • Prednizon

    Brands, generics, trade names:

  • Apo-Prednisone - Apotex, Nhan Tam, Pharmaforte
  • Artinizona - Teuto-Brasileiro Laboratorio
  • Cortancyl - Sanofi
  • Corticorten - Neo Quimica Comercio e Industria Laboratorio
  • Cortiprex - Chile Laboratorios
  • Dacortin - Merck
  • Decortin - Merck
  • Dekortin - Merck
  • Deltacortene - Bruno Farmaceutici
  • Deltasone - Pfizer
  • Deltison - Recipharm
  • Encorton - Polfa Pabianice
  • Hostacortin - Sanofi
  • Lodotra - Mundipharma
  • Meticorten - Bayer Schering Pharma, Essex, Schering-Plough
  • Nisona - Unidos Laboratorios
  • Nosipren - Collins Productos Farmaceuticos
  • Novo-Prednisone - Novopharm
  • Orasone - Solvay
  • Panafcort - Aspen
  • Pred - Prosel Pharma
  • Predni Tablinen - Hexal, Lichtenstein Pharmazeutica
  • Prednison - Acis Arzneimittelvertrieb, G. Streuli, Hexal, Ratiopharm, Sandoz
  • Prednisona - Cinfa Laboratorios, Kern Pharma, Rider Laboratorios, Sanofi
  • Prednisone - Arrow Generiques, Biogaran, EG Labo, Mylan, Organon, Roxane Laboratories, Sandoz, Teva
  • Prednisone Intensol - Roxane Laboratories
  • Pronison - Galenika
  • Pulmison - Boehringer Ingelheim
  • Rayos - Horizon Therapeutics
  • Rectodelt - Trommsdorff Arzneimittel, Afamia Trade, R-Mark
  • Sterapred - Merz
  • Ultracorten - Novartis

    APIs used in medicine in combinations with prednisone:

  • Aspirin
  • Benzocaine
  • Chloramphenicol
  • Chlorpheniramine
  • Diphenhydramine
  • Ephedrine
  • Hydrocortisone
  • Indometacin
  • Methoxyphenamine
  • Neomycin
  • Papaverine
  • Pheniramine
  • Phenobarbital
  • Phenylbutazone
  • Piroxicam
  • Pyrilamine
  • Tetracycline
  • Theophylline
  • Vitamins

    Here is a list of popular medications containing prednisone as a main active pharmaceutical ingredient; their trade names, forms, doses, companies - manufacturers, distributors, suppliers, researchers and developers:

    Trade name of the drug Pharmaceutical forms and doses Companies
    • Tablets; Oral; Prednisone 2.5 mg
    • Tablets; Oral; Prednisone 5 mg
    • Tablets; Oral; Prednisone 10 mg
    • Tablets; Oral; Prednisone 20 mg
    • Tablets; Oral; Prednisone 50 mg
    • Pfizer
    • Tablets, Prolonged Release; Oral; Prednisone 1 mg
    • Tablets, Prolonged Release; Oral; Prednisone 2 mg
    • Tablets, Prolonged Release; Oral; Prednisone 5 mg
    • Mundipharma
    • Aenova Group
    • Horizon Pharma
    • Tablets; Oral; Prednisone 1 mg
    • Tablets; Oral; Prednisone 5 mg
    • Tablets; Oral; Prednisone 10 mg
    • Tablets; Oral; Prednisone 20 mg
    • Tablets; Oral; Prednisone 50 mg
    • Solvay
    • Phoenix Pharmaceuticals
    • Tablets; Oral; Prednisone 1 mg
    • Tablets; Oral; Prednisone 5 mg
    • Tablets; Oral; Prednisone 25 mg
    • Aspen
    • Adcock Ingram
    • Tablets; Oral; Prednisone 5 mg
    • Tablets; Oral; Prednisone 10 mg
    • Tablets; Oral; Prednisone 20 mg
    • Boehringer Ingelheim


  • Prednisone main article on Wikipedia: https://en.wikipedia.org/wiki/Prednisone
  • Prednisone compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Prednisone
  • Prednisone medicine on DrugBank: https://go.drugbank.com/drugs/DB00635
  • Prednisone FAQ on MedlinePlus (revised 03/15/2020): https://medlineplus.gov/druginfo/meds/a601102.html
  • Deltasone (Prednisone) tablets drug label on DailyMed (revised November 2, 2018): https://dailymed.nlm.nih.gov/dailymed/lookup...
  • Prednisone tablets drug label on DailyMed (revised December 17, 2019): https://dailymed.nlm.nih.gov/dailymed/drugInfo...
  • Prednisone for sale on Pharma Doctor (revised February 2022): https://pharma-doctor.com/prednisone.html
  • Prednisone containing drugs on Drugs-About.com: https://drugs-about.com/ing/prednisone.html
  • Rayos (Prednisone) delayed-release tablets 1 mg, 2 mg, 5 mg official prescribing information from the U.S. FDA (revised July 2012): https://www.accessdata.fda.gov/drugsatfda_docs/label...
  • Deltasone (Prednisone) tablets prescribing information from Drugs.com (revised August 2006): https://www.drugs.com/pro/deltasone.html
  • Lodotra (Prednisone) 1 mg, 2 mg and 5 mg modified release tablets product information from GP2U TeleHealth (revised 7 August 2012): https://gp2u.com.au/static/pdf/L/LODOTRA-PI.pdf
  • Panafcort (Prednisone) tablets product information from The Therapeutic Goods Administration (revised 19 April 2021): https://www.ebs.tga.gov.au/ebs/picmi/...
  • Prednisone (Deltasone) patient fact sheet from American College of Rheumatology: https://www.rheumatology.org/Portals/0/Files/...

    Revised: February 2022

Preclinical Testing Solutions
Throughout the
Product Innovation Cycle.